Lazari Capital Management Inc. Purchases 2,532 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Lazari Capital Management Inc. increased its stake in UnitedHealth Group by 271.7%, owning a total of 3,464 shares valued at approximately $1.08 million after purchasing an additional 2,532 shares.
• UnitedHealth Group reported a quarterly EPS of $4.08, missing analyst expectations, while its revenue reached $111.62 billion, reflecting a 12.9% year-over-year increase.
• The company recently announced a quarterly dividend of $2.21 per share, translating to an annualized dividend yield of 2.6% and a dividend payout ratio of 38.30%.

Lazari Capital Management Inc. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 271.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,464 shares of the healthcare conglomerate's stock after purchasing an additional 2,532 shares during the period. Lazari Capital Management Inc.'s holdings in UnitedHealth Group were worth $1,081,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Citizens National Bank Trust Department lifted its stake in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after purchasing an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH increased its holdings in UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Caitlin John LLC increased its holdings in UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management purchased a new stake in shares of UnitedHealth Group during the second quarter worth $1,324,000. Finally, Wealth Effects LLC grew its holdings in shares of UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate's stock worth $1,463,000 after buying an additional 591 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.4%

Shares of UNH stock opened at $344.15 on Monday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market cap of $311.69 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 2.24 and a beta of 0.44. The company has a 50-day moving average of $301.20 and a two-hundred day moving average of $358.73. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Barclays upped their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a report on Thursday, September 4th. Royal Bank Of Canada dropped their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.